Key result
Genetic liability to irregular menses is linked to ~17% higher risk of myocardial infarction.
Observational
Mendelian randomization
Yes
Answers are grounded in this paper and cite their sources.
Background Observational studies have demonstrated associations between menstrual disorders, dysmenorrhea, and cardiovascular disease (CVD). However, it remains unclear whether these associations are causal. This study is to investigate whether menstrual disorders and dysmenorrhea causally affect the risk of CVD. Methods The summary data for menstrual disorders (excessive menstruation and irregular menses) and dysmenorrhea were obtained from FinnGen study, summary data for CVD were obtained from UK Biobank and meta-analysis. The inverse-variance-weighted method was mainly used in the Mendelian randomization for causality analysis. Sensitivity analyses were performed by several methods under different model assumptions. Results Genetic liability to excessive menstruation was associated with higher risk of atrial fibrillation (odds ratio (OR), 1.078 [95% confidence interval (CI), 1.015-1.145]; P =0.014), but a lower risk of hypertension (OR, 0.994 [95% CI: 0.989-0.999]; P =0.016). Irregular menses was associated with higher risk of atrial fibrillation (OR, 1.095 [95% CI: 1.015-1.182]; P =0.02), hypertension (OR, 1.007 [95% CI: 1.000-1.013]; P =0.047), myocardial infarction (OR, 1.172 [95% CI: 1.060-1.295]; P =0.02), ischemic heart disease, (OR, 1.005 [95% CI: 1.000-1.010]; P =0.037) and coronary heart disease (OR, 1.004 [95% CI: 1.001-1.008]; P =0.026). Dysmenorrhea was associated with higher risk of atrial fibrillation (OR, 1.052 [95% CI: 1.014-1.092]; P =0.008) and Ischemic stroke (cardioembolic) (OR, 1.122 [95% CI: 1.002-1.257]; P =0.046). After Benjamini-Hochberg correction, irregular menses was associated with higher risk of myocardial infarction. Conclusion We confirmed a causal relationship of excessive menstruation, irregular menses and dysmenorrhea on cardiovascular outcomes independent of sex hormone levels, with an emphasis on the link between irregular menses and myocardial infarction. These clinical features can be utilized as markers to identify women at higher risk of developing CVD in the future, recommending early clinical intervention of menstrual diseases.
No takes yet. Share an insight, caveat, or question.
Lai et al. (2024) conducted an observational in Cardiovascular disease, menstrual disorders, and dysmenorrhea. Genetic liability to menstrual disorders (excessive menstruation, irregular menses) and dysmenorrhea vs. Absence of genetic liability to menstrual disorders and dysmenorrhea was evaluated on Myocardial infarction (associated with irregular menses after Benjamini-Hochberg correction) (OR 1.172, 95% CI 1.060-1.295, p=0.02). Genetic liability to irregular menses was causally associated with a higher risk of myocardial infarction after Benjamini-Hochberg correction.
Synapse has enriched 10 related papers. Consider them for comparative context: